Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus - Test2 - elhamkhani - TriplyDB

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

http://www.wikidata.org/entity/Q30828464

about

Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus Autoantigen Microarray for High-throughput Autoantibody Profiling in Systemic Lupus Erythematosus Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus The deleterious role of basophils in systemic lupus erythematosus Emerging therapies for systemic lupus erythematosus--focus on targeting interferon-alpha Interferon alpha-induced lupus: proof of principle Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus.Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside.Systemic lupus erythematosus diagnostics in the 'omics' era Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.Interferon-alpha: a therapeutic target in systemic lupus erythematosus Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Recent advances in the genetics of systemic lupus erythematosus.Pharmacological characterization of a small-molecule agonist for the chemokine receptor CXCR3 Deficiency of the type I interferon receptor protects mice from experimental lupus.Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.Urinary biomarkers in lupus nephritis.Using gene expression to improve the power of genome-wide association analysis.Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort Protein analysis by shotgun/bottom-up proteomics Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus.Systems biology approaches to new vaccine development.Association of IRF5 polymorphisms with activation of the interferon alpha pathway Smoking decreases structural and functional resilience in the subgingival ecosystem.The dysregulation of cytokine networks in systemic lupus erythematosus.Biomarkers identified from serum proteomic analysis for the differential diagnosis of systemic lupus erythematosus.Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathways Cytokine disturbances in systemic lupus erythematosus.Delivery of siRNA to the mouse lung via a functionalized lipopolyamine.Tobacco smoking affects bacterial acquisition and colonization in oral biofilms.Biologic predictors of clinical improvement in rituximab-treated refractory myositis Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice.

P2860

Q22306446-DE55F093-5741-4A60-B023-9E0EB64BC839 Q26746697-E18C19A3-EAF7-49C1-81E5-1238C35A1C46 Q26753174-85B320B8-43A8-453E-97FA-8604B2AEFF07 Q26782454-4D92550B-1B19-4C04-8963-4A38A4D19E51 Q26785472-659897E8-DAAF-4439-A5F3-F0695FF4FA52 Q26822662-314976AD-4750-4AFB-8A31-696AB466D287 Q27693310-51FD64DD-1024-4225-B7C1-02C88CB6F47A Q28265144-76CCAA08-0204-4475-BE02-54411610D22D Q28282720-F5F88A66-81D6-43D5-A003-492058145BDD Q28743723-699C5ED2-78DF-4703-BB08-284DB4D59359 Q30873883-AC5CD429-88C2-41E3-A433-1C269E6CB6E1 Q33339386-469A8886-4FF4-49AD-A170-BE093555FB96 Q33622723-A411F90F-AF3B-46D0-B567-E08E45A152E3 Q33644106-86B965AB-0580-4A08-A17C-BEF5729F293C Q33743791-A9463815-558F-4B88-AE83-407579B8B40E Q33744320-AA05855B-A633-426A-B03F-042DB93DF98B Q33829507-85AA64A7-2424-4462-99A8-2C5D4095943D Q33884499-0CC05BF0-3E8E-4F38-A1C6-AC59688D1B08 Q33891197-0FA6C2D3-C747-4588-AF47-EA4E4CF6E115 Q33964547-45F0E7BD-0F45-45B6-A4AB-7F90FE0B5999 Q34007358-3A97C6C7-4ECC-46BC-9BD1-67788C5E16BD Q34016334-673C63EF-A5E3-4F0A-A6FD-4B0B160E5BA7 Q34027485-B6DE9081-8B4D-47DF-9168-8968CFCDCC2C Q34050022-FB4E9391-9332-4894-B7E5-B2D47327555D Q34125423-5B37ECBF-8608-4FDB-9AB2-D16A28A43F04 Q34161393-4759B829-AF81-48BA-AFE4-B24CC5C804DC Q34600986-CC0DCB6D-D47F-4A41-8615-1FEAB4E5314E Q34613920-E4985E04-1163-4114-ADE7-8E883643391E Q35086204-C16CBB98-437A-4E17-B52E-C067E06C2105 Q35102479-6AC109BA-5117-44D3-98EC-A13653454585 Q35228341-817C0F91-D8ED-4CB5-AB1E-7113F1C31575 Q35294513-46063A34-CD69-4440-9402-5578C1BD262C Q35415454-84FF086F-9231-4757-864B-F3E72F23677C Q35557898-301AD4D7-5B6A-4952-A5AA-8478A0182524 Q35574404-87579D45-3381-47C8-88D9-35115ACBE1C9 Q35617573-E4CC67BD-B371-452E-A7F8-5FB9C7C521B6 Q35665154-1591D380-7544-44CC-87FC-99694D5465C8 Q35671586-F80ADEA5-CBBC-45F4-ABAB-922370B564E8 Q35779841-8BC10F2F-9E38-487B-9339-54F0C97EAED2 Q35791280-EEDC623F-EC28-4196-979A-52022C24E917

P2860

Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus

http://www.wikidata.org/entity/Q30828464

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Elevated serum levels of inter ...... n systemic lupus erythematosus

@ast

Elevated serum levels of inter ...... n systemic lupus erythematosus

@en

type

label

Elevated serum levels of inter ...... n systemic lupus erythematosus

@ast

Elevated serum levels of inter ...... n systemic lupus erythematosus

@en

prefLabel

Elevated serum levels of inter ...... n systemic lupus erythematosus

@ast

Elevated serum levels of inter ...... n systemic lupus erythematosus

@en

P1433

Q30828464-8ED6D047-BD63-4FBE-94FE-9C9AF7A55833

P1476

Q30828464-30107E89-90E4-4C60-AA53-DC87CB8500BB

P2093

Q30828464-0B85E66E-3410-4027-870A-CDAC2C0D2378

Q30828464-2311B7F6-D170-4D5F-B129-A496D37B5DC8

Q30828464-24BE73D4-F6BA-4151-B6CA-C9A21DE0ED11

Q30828464-25390031-4C23-4B8F-BB74-782896BFB0C8

Q30828464-51AA9E80-C746-4EED-B166-6B597802E770

Q30828464-5922884C-9072-429B-8B9A-93A00D2B9079

Q30828464-73C12C11-B30A-4F3D-94B6-5DC2576DC000

Q30828464-84AC2DF2-BC28-4836-BC6A-AC7CE0C65147

Q30828464-F39F02EB-F34F-4E37-9D1B-B2399DA90B9B

P2860

Q30828464-05AA5A46-BF18-46F1-9465-8615A70570AA

Q30828464-0AB5C4D6-94FA-42DE-936B-6D9E1F676259

Q30828464-16EDC1E8-5DF0-482F-9BC0-8C1E15B45527

Q30828464-16F5AB14-5F94-49BD-92E6-9CCC4029820A

Q30828464-1CC5C254-156A-43A1-9E27-81BA7A274DC7

Q30828464-2FB4A923-6C9F-453C-B66D-14B866250EDD

Q30828464-37692A2D-1E06-468B-8B5F-0E9563F04EA8

Q30828464-3E6FAA8E-4254-4D59-90D4-ACF2A2CDB578

Q30828464-41F2B480-1D90-4F2C-9012-C01A9540DF07

Q30828464-4838968F-65C1-47E9-96D0-07D8DA7443CB

P304

Q30828464-ED6B0BB6-9A3F-43A1-A122-3AC5192B0968

P31

Q30828464-5DD639F0-F6BB-4CFD-9A30-4CCD81EDA67B

P356

Q30828464-E8296B82-A7BC-466A-B117-29E520480F03

P407

Q30828464-6A335327-5ADF-4D66-A2FD-502A0F41DB0F

P433

Q30828464-975BCBEF-0998-4845-B256-13F70B7A124A

P478

Q30828464-3820B560-81DF-4FC7-9E7E-3C055F3165F1

P50

Q30828464-594EF118-7E0E-4326-A6A4-C29DC4D2D3CE

Q30828464-86E3FF70-E256-466C-9F68-3BF84E65E0E4

P577

Q30828464-17C89014-D03B-4DC8-8D87-C2A002A31911

P5875

Q30828464-FF100FE2-D18C-4AFF-AF03-96F8AD64074D

P698

Q30828464-155E9E34-DE03-4C1C-A863-EE7E5210D505

P921

Q30828464-276A880B-D083-4407-8FF3-9B7FE1AE0635

P932

Q30828464-A9D28779-3463-413E-B3FD-52511707752F

P356

JOURNAL.PMED.0030491

P1433

P1476

Elevated serum levels of inter ...... n systemic lupus erythematosus

@en

P2093

Dhavalkumar D Patel

http://www.w3.org/2001/XMLSchema#string

Dianna Crawford

http://www.w3.org/2001/XMLSchema#string

Emily C Baechler

http://www.w3.org/2001/XMLSchema#string

Franak M Batliwalla

http://www.w3.org/2001/XMLSchema#string

Jason W Bauer

http://www.w3.org/2001/XMLSchema#string

Karl J Espe

http://www.w3.org/2001/XMLSchema#string

Timothy W Behrens

http://www.w3.org/2001/XMLSchema#string

Ward A Ortmann

http://www.w3.org/2001/XMLSchema#string

Wentian Li

http://www.w3.org/2001/XMLSchema#string

P2860

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

Cluster analysis and display of genome-wide expression patterns

Optimization of Rolling-Circle Amplified Protein Microarrays for Multiplexed Protein Profiling

Development and standardization of multiplexed antibody microarrays for use in quantitative proteomics

Virus interference. I. The interferon

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

More powerful procedures for multiple significance testing

Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

P304

e491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.0030491

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A. Petri

Peter K. Gregersen

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6621824

http://www.w3.org/2001/XMLSchema#string

P698

17177599

http://www.w3.org/2001/XMLSchema#string

P921

P932

1702557

http://www.w3.org/2001/XMLSchema#string